Interestingly, a recent study collecting circulating tumor cells from patients treated with AR signaling inhibitors demonstrated that detection of multiple NE markers — independent of the loss of AR target gene expression — was sufficient for the detection of NEPC. The gene discussed is AR; the disease is neoplasm.